A Pharmacogenetic Study of Psoriasis Risk Variants in a Greek Population and Prediction of Responses to Anti-TNF-α and Anti-IL-12/23 Agents.
about
A systematic review of pharmacogenetic studies on the response to biologics in psoriasis patients.Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis.The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis.Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.Genetic polymorphism in psoriasis and its meaning for the treatment efficacy in the future
P2860
Q36413825-B0632812-546D-405A-96C6-6051F654E6BFQ38684354-31D12BFB-F330-4087-BF70-6460D5907BE5Q39218034-F16653C3-5A9A-43E9-8014-A1779A45FA31Q47786696-22B989C0-45BA-43B3-848F-CE9FD6E75D51Q48020447-70EF82A2-E114-4CC9-80FF-8D08CC0FA825Q50177371-ED275C39-B690-4E3C-9ED6-612597848199Q57173480-4A96AC55-4D69-4204-94DA-66FABDD32A69
P2860
A Pharmacogenetic Study of Psoriasis Risk Variants in a Greek Population and Prediction of Responses to Anti-TNF-α and Anti-IL-12/23 Agents.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Pharmacogenetic Study of Pso ...... NF-α and Anti-IL-12/23 Agents.
@en
type
label
A Pharmacogenetic Study of Pso ...... NF-α and Anti-IL-12/23 Agents.
@en
prefLabel
A Pharmacogenetic Study of Pso ...... NF-α and Anti-IL-12/23 Agents.
@en
P2093
P2860
P1476
A Pharmacogenetic Study of Pso ...... NF-α and Anti-IL-12/23 Agents.
@en
P2093
Alexandros John Stratigos
Christina Antoniou
Eleni Drakaki
Giorgos Ntritsos
Irene Stefanaki
Katerina P Kypreou
Sofia Masouri
P2860
P2888
P304
P356
10.1007/S40291-016-0198-Z
P577
2016-04-04T00:00:00Z